Active substance
Diflucortolone
- SFDA 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| NERISONE 0.1% CREAM | 0.1 % | Cream · Topical | 1 Tube | SAR 17.65 | NCE · Prescription | INTENDIS MANUFACTURING S.P.A. | Withdrawn by MAH · Not Marketed |
| NERISONE 0.1% FATTY OINTMENT | 0.1 % | Ointment · Topical | 1 Tube | SAR 17.65 | NCE · Prescription | INTENDIS MANUFACTURING S.P.A. | Withdrawn by MAH · Not Marketed |
| NERISONE 0.1% OINTMENT | 0.1 % | Ointment · Topical | 1 Tube | SAR 17.65 | NCE · Prescription | INTENDIS MANUFACTURING S.P.A. | Withdrawn by MAH · Not Marketed |
Combinations containing Diflucortolone
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.